Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-19

FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA has approved a supplemental application for Quinapril submitted by BluePoint Laboratories. The action updates the regulatory status of this ACE inhibitor un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quinapril (quinapril)

Snippet

SUPPL AP for QUINAPRIL (QUINAPRIL)